Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer. [electronic resource]
Producer: 20130111Description: 1635-46 p. digitalISSN:- 1460-2105
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- genetics
- Camptothecin -- administration & dosage
- Chemotherapy, Adjuvant
- Chromosomes, Human, Pair 18 -- genetics
- Colonic Neoplasms -- drug therapy
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Humans
- Immunohistochemistry
- Irinotecan
- Kaplan-Meier Estimate
- Leucovorin -- administration & dosage
- Loss of Heterozygosity
- Male
- Microsatellite Instability
- Middle Aged
- Multivariate Analysis
- Mutation
- Neoplasm Staging
- Predictive Value of Tests
- Prognosis
- Proportional Hazards Models
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins B-raf -- genetics
- Proto-Oncogene Proteins p21(ras)
- Research Design
- Smad4 Protein -- metabolism
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.